{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:58Z","timestamp":1790735938215,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,27]]},"DOI":"10.1097\/tp.0b013e31825475a3","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T23:04:49Z","timestamp":1340319889000},"page":"152-158","source":"Crossref","is-referenced-by-count":45,"title":["Mycophenolate Versus Azathioprine for Kidney Transplantation"],"prefix":"10.1097","volume":"94","author":[{"given":"Philip A.","family":"Clayton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Chadban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","first-page":"1321","article-title":"European Mycophenolate Mofetil Cooperative Study Group.","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"R2-8-20210129","first-page":"1029","article-title":"The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":". Immunosuppression: evolution in practice and trends, 1994-2004.","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00007890-199502270-00002","article-title":". Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts.","volume":"59","author":"Azuma","year":"1995","journal-title":"Transplantation"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0966-3274(95)80021-2","article-title":". Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts.","volume":"3","author":"Raisanen-Sokolowski","year":"1995","journal-title":"Transpl Immunol"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/TP.0b013e318199c1c7","article-title":"Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.","volume":"87","author":"Opelz","year":"2009","journal-title":"Transplantation"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1681\/ASN.2006101153","article-title":". Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.","volume":"18","author":"Remuzzi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1600-6143.2009.02756.x","article-title":"AZAtacrolimus is associated with similar outcomes as MMFtacrolimus among renal transplant recipients.","volume":"9","author":"Schold","year":"2009","journal-title":"Am J Transplant"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/01.tp.0000250713.65004.35","article-title":". Long-term graft outcome with mycophenolate mofetil and azathioprine: a paired kidney analysis.","volume":"82","author":"Shah","year":"2006","journal-title":"Transplantation"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal.","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00007890-199806150-00007","article-title":"A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.","volume":"65","author":"Mathew","year":"1998","journal-title":"Transplantation"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0272-6386(99)70358-6","article-title":"US Renal Transplant Mycophenolate Mofetil Study Group.","volume":"34","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":". Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/TP.0b013e3181952623","article-title":". Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.","volume":"87","author":"Knight","year":"2009","journal-title":"Transplantation"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":". Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-6143.2003.30112.x","article-title":". Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection.","volume":"3","author":"Meier-Kriesche","year":"2003","journal-title":"Am J Transplant"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.TP.0000062833.14843.4B","article-title":". Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.","volume":"75","author":"Meier-Kriesche","year":"2003","journal-title":"Transplantation"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/00007890-199712270-00013","article-title":". A novel approach to the treatment of chronic allograft nephropathy.","volume":"64","author":"Weir","year":"1997","journal-title":"Transplantation"},{"key":"R22-8-20210129","first-page":"155A","article-title":". A simplified equation to predict glomerular filtration rate from serum creatinine abstract.","volume":"11","author":"Levey","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R23-8-20210129","first-page":"289","article-title":"C, et al..","volume":"65","author":"Mariat","year":"2004","journal-title":"Assessing renal graft function in clinical trials: can tests predicting glomerular filtration rate substitute for a reference method Kidney Int"},{"key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":". A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":". Predicting glomerular filtration rate after kidney transplantation.","volume":"59","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1440-1797.2010.01297.x","article-title":". Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).","volume":"15","author":"Webster","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201207270-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:46:53Z","timestamp":1618278413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201207270-00008"}},"subtitle":["A 15-Year Follow-Up of a Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2012,7,27]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31825475a3","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,27]]}}}